Gurpreet Rekhi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gurpreet Rekhi has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Jimmy Lee
Research Division, Institute of Mental Health, Singapore
7 shared publications- Jimmy Lee
Institute of Mental Health, Singapore
5 shared publications Mei San Ang
Research Division, Institute of Mental Health, Singapore, Singapore
5 shared publicationsAttilio Rapisarda
Research Division, Institute of Mental Health, Singapore, Singapore
2 shared publicationsBrian Kirkpatrick
Department of Psychiatry & Behavioral Sciences, University of Nevada, Reno School of Medicine, United States
2 shared publications- Emilio Fernandez-Egea
University of Cambridge
2 shared publications
Latest Publications
- Open Access
- 28 January 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (2) , 215
Impact of Cognitive Impairments on Health-Related Quality of Life in Schizophrenia
The impact of cognitive impairments on the health-related quality of life (HRQoL) in individuals with schizophrenia is unclear. The aim of this study was to examine the association between cognitive impairments and HRQoL in individuals with schizophrenia. A total of 609 individuals with schizophrenia were assessed on the Positive and Negative Syndrome Scale (PANSS) and a neurocognitive battery which comprised of the Wechsler Abbreviated Scale of Intelligence matrix reasoning, the Benton Judgment of Line Orientation Test, Continuous Performance Tests-Identical Pairs, and the Brief Assessment of Cognition in Schizophrenia. A cognitive factor g was derived from the neurocognitive battery. EuroQol five-dimensional (EQ-5D-5L) utility scores were derived from PANSS scores via a previously validated algorithm and used as a measure of HRQoL. Hierarchical multiple regression was conducted to examine the association between cognitive factor g and the EQ-5D-5L. Cognitive factor g (β = 0.189, t = 4.956, p < 0.001) was found to be significantly associated with EQ-5D-5L scores. Age (β = −0.258, t = −6.776, p < 0.001), sex (β = 0.081, t = 2.117, p = 0.035), and being employed (β = 0.091, t = 2.317, p = 0.021) were also significant predictors of EQ-5D-5L. Our results add to the extant literature on the burden cognitive impairments exact in individuals with schizophrenia. More research is needed to develop effective interventions for cognitive impairments in schizophrenia.
- 28 January 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (2) , 215
Open AccessImpact of Cognitive Impairments on Health-Related Quality of Life in Schizophrenia
The impact of cognitive impairments on the health-related quality of life (HRQoL) in individuals with schizophrenia is unclear. The aim of this study was to examine the association between cognitive impairments and HRQoL in individuals with schizophrenia. A total of 609 individuals with schizophrenia were assessed on the Positive and Negative Syndrome Scale (PANSS) and a neurocognitive battery which comprised of the Wechsler Abbreviated Scale of Intelligence matrix reasoning, the Benton Judgment of Line Orientation Test, Continuous Performance Tests-Identical Pairs, and the Brief Assessment of Cognition in Schizophrenia. A cognitive factor g was derived from the neurocognitive battery. EuroQol five-dimensional (EQ-5D-5L) utility scores were derived from PANSS scores via a previously validated algorithm and used as a measure of HRQoL. Hierarchical multiple regression was conducted to examine the association between cognitive factor g and the EQ-5D-5L. Cognitive factor g (β = 0.189, t = 4.956, p < 0.001) was found to be significantly associated with EQ-5D-5L scores. Age (β = −0.258, t = −6.776, p < 0.001), sex (β = 0.081, t = 2.117, p = 0.035), and being employed (β = 0.091, t = 2.317, p = 0.021) were also significant predictors of EQ-5D-5L. Our results add to the extant literature on the burden cognitive impairments exact in individuals with schizophrenia. More research is needed to develop effective interventions for cognitive impairments in schizophrenia.
- 4 March 2022
- Published by Elsevier in Spanish Journal of Psychiatry and Mental Health
- Vol. 15 (1) , 3-13
Defining negative symptoms remission in schizophrenia using the Brief Negative Symptom Scale
- 4 March 2022
- Published by Elsevier in Spanish Journal of Psychiatry and Mental Health
- Vol. 15 (1) , 3-13
Defining negative symptoms remission in schizophrenia using the Brief Negative Symptom Scale
- 3 January 2022
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 36 (2) , 183-190
Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia
Both drug-induced Parkinsonism (DIP) and tardive dyskinesia (TD) have been shown to be associated with lower health-related quality of life (HRQOL) in schizophrenia, but few studies have examined their relative impact. This study aimed to examine and compare the association of DIP and TD with HRQOL in schizophrenia. In total, 903 patients with schizophrenia were assessed on the Positive and Negative Syndrome Scale (PANSS), Simpson-Angus Scale (SAS), and Abnormal Involuntary Movement Scale (AIMS). EuroQoL five-dimensional (EQ-5D-5L) utility scores were derived from PANSS scores via a previously validated algorithm and used as a measure of HRQOL. In total, 160 (17.7%) participants had only DIP, 119 (13.2%) had only TD, and 123 (13.6%) had both DIP and TD. HRQOL was lowest for participants with both DIP and TD, followed by only DIP group, only TD group, and highest in the group with neither condition. HRQOL scores differed significantly between the four groups, F(3, 892) = 13.724, p < 0.001, = 0.044). HRQOL of participants having only DIP or both DIP and TD was significantly lower than those having neither condition. There was no significant interaction between the presence of DIP and TD on the association with HRQOL. DIP was the main antipsychotic-induced movement disorder associated with a poorer HRQOL in patients with schizophrenia. Therefore, clinicians should focus on prevention, detection, and effective management of DIP to optimize HRQOL in patients with schizophrenia.- 3 January 2022
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 36 (2) , 183-190
Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia
Both drug-induced Parkinsonism (DIP) and tardive dyskinesia (TD) have been shown to be associated with lower health-related quality of life (HRQOL) in schizophrenia, but few studies have examined their relative impact. This study aimed to examine and compare the association of DIP and TD with HRQOL in schizophrenia. In total, 903 patients with schizophrenia were assessed on the Positive and Negative Syndrome Scale (PANSS), Simpson-Angus Scale (SAS), and Abnormal Involuntary Movement Scale (AIMS). EuroQoL five-dimensional (EQ-5D-5L) utility scores were derived from PANSS scores via a previously validated algorithm and used as a measure of HRQOL. In total, 160 (17.7%) participants had only DIP, 119 (13.2%) had only TD, and 123 (13.6%) had both DIP and TD. HRQOL was lowest for participants with both DIP and TD, followed by only DIP group, only TD group, and highest in the group with neither condition. HRQOL scores differed significantly between the four groups, F(3, 892) = 13.724, p < 0.001, = 0.044). HRQOL of participants having only DIP or both DIP and TD was significantly lower than those having neither condition. There was no significant interaction between the presence of DIP and TD on the association with HRQOL. DIP was the main antipsychotic-induced movement disorder associated with a poorer HRQOL in patients with schizophrenia. Therefore, clinicians should focus on prevention, detection, and effective management of DIP to optimize HRQOL in patients with schizophrenia.- 1 January 2022
- Published by Elsevier in Revista de Psiquiatría y Salud Mental
- Vol. 15 (1) , 3-13
Defining negative symptoms remission in schizophrenia using the Brief Negative Symptom Scale
- 1 January 2022
- Published by Elsevier in Revista de Psiquiatría y Salud Mental
- Vol. 15 (1) , 3-13
Defining negative symptoms remission in schizophrenia using the Brief Negative Symptom Scale
- 1 January 2021
- Published by Elsevier in General Hospital Psychiatry
- Vol. 68, 83-89
Association between negative symptom domains and happiness in schizophrenia
- 1 January 2021
- Published by Elsevier in General Hospital Psychiatry
- Vol. 68, 83-89
Association between negative symptom domains and happiness in schizophrenia
- 1 December 2019
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 29 (12) , 1433-1441
Clinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia
- 1 December 2019
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 29 (12) , 1433-1441
Clinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia
- Open Access
- 20 November 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (11) , e0225370
Clinical determinants of social media use in individuals with schizophrenia
This study aimed to examine the prevalence of social media use and its association with symptoms in individuals with schizophrenia. 265 individuals with schizophrenia were assessed. Symptoms were assessed on the Positive and Negative Syndrome Scale (PANSS) and the Clinical Assessment Interview for Negative Symptoms (CAINS). Information on social media use was collected. Logistic regressions were used to explore the association between social media use and socio-demographic and clinical characteristics of the participants. Of the 265 study participants, 139 (52.5%) used social media in the last week. Fifty-six (21.1%) of the study participants used more than one social media site in the last week. Facebook was the most popular social media site. Age, highest education level, monthly household income, PANSS negative and depression factor scores were significantly associated with social media use. Amongst negative symptoms, the CAINS motivation-pleasure (MAP) social factor scores were found to be significantly associated with social media use. Our study results suggested that the assessment of social interactions via social media should be considered in the clinical assessment of individuals with schizophrenia. Secondly, our results suggested that the development of treatment programs supported by social media platforms may be useful for certain groups of individuals with schizophrenia. Younger patients with above secondary level education, higher family income and lower symptom severity are likely to be avid users of social media and would be suitable candidates to receive illness related information or clinical interventions via social media.
- 20 November 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (11) , e0225370
Open AccessClinical determinants of social media use in individuals with schizophrenia
This study aimed to examine the prevalence of social media use and its association with symptoms in individuals with schizophrenia. 265 individuals with schizophrenia were assessed. Symptoms were assessed on the Positive and Negative Syndrome Scale (PANSS) and the Clinical Assessment Interview for Negative Symptoms (CAINS). Information on social media use was collected. Logistic regressions were used to explore the association between social media use and socio-demographic and clinical characteristics of the participants. Of the 265 study participants, 139 (52.5%) used social media in the last week. Fifty-six (21.1%) of the study participants used more than one social media site in the last week. Facebook was the most popular social media site. Age, highest education level, monthly household income, PANSS negative and depression factor scores were significantly associated with social media use. Amongst negative symptoms, the CAINS motivation-pleasure (MAP) social factor scores were found to be significantly associated with social media use. Our study results suggested that the assessment of social interactions via social media should be considered in the clinical assessment of individuals with schizophrenia. Secondly, our results suggested that the development of treatment programs supported by social media platforms may be useful for certain groups of individuals with schizophrenia. Younger patients with above secondary level education, higher family income and lower symptom severity are likely to be avid users of social media and would be suitable candidates to receive illness related information or clinical interventions via social media.
- Open Access
- 1 April 2019
- Published by Elsevier in Schizophrenia Research
- Vol. 206, 177-182
Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore
- 1 April 2019
- Published by Elsevier in Schizophrenia Research
- Vol. 206, 177-182
Open AccessAssessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore
- Open Access
- 13 July 2017
- Published by Elsevier in Schizophrenia Research
- Vol. 193, 423-427
Clinical utility of the Calgary Depression Scale for Schizophrenia in individuals at ultra-high risk of psychosis
- 13 July 2017
- Published by Elsevier in Schizophrenia Research
- Vol. 193, 423-427
Open AccessClinical utility of the Calgary Depression Scale for Schizophrenia in individuals at ultra-high risk of psychosis
- 31 May 2017
- Published by Wiley in Early Intervention in Psychiatry
- Vol. 13 (1) , 73-78
Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study
Aim: Recent studies have highlighted that attenuated psychotic symptoms (APS) are an important source of distress in ultra high risk (UHR) individuals and that this distress is related to transition to psychosis (TTP). This study examined distress associated with APS in UHR individuals and investigated its association with TTP.Methods: The Comprehensive Assessment of At‐Risk Mental State (CAARMS) was used to identify 173 UHR individuals, who were included as participants in the study. Distress related to APS was self‐reported. Functioning was assessed on the Social and Occupational Functioning Assessment Scale. Associations between each of the 4 APS subscales in the CAARMS—non‐bizarre ideas (NBI), perceptual abnormalities (PA), unusual thought content (UTC) and disorganized speech (DS)—with its distress level were examined.Results: Of the 173 UHR participants, 154 (89%) reported distress related to one or more APS. NBI was rated to be the most distressing out of the 4 APS by the highest number of participants (32.9%) compared to UTC (12.1%), PA (24.9%) and DS (2.9%). Mean distress scores were significantly associated with CAARMS composite scores (P < .001). However, there was no significant relationship between distress scores and functioning. Both mean distress scores (OR = 1.034, P = .029) and functioning (OR = 0.892, P = .022) were significant predictors of transition to psychosis at 1 year of follow‐up.Conclusions: This study provides additional evidence to link subjective distress experienced by UHR individuals to APS and to their subsequent clinical outcomes and has significant clinical implications.
- 31 May 2017
- Published by Wiley in Early Intervention in Psychiatry
- Vol. 13 (1) , 73-78
Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study
Aim: Recent studies have highlighted that attenuated psychotic symptoms (APS) are an important source of distress in ultra high risk (UHR) individuals and that this distress is related to transition to psychosis (TTP). This study examined distress associated with APS in UHR individuals and investigated its association with TTP.Methods: The Comprehensive Assessment of At‐Risk Mental State (CAARMS) was used to identify 173 UHR individuals, who were included as participants in the study. Distress related to APS was self‐reported. Functioning was assessed on the Social and Occupational Functioning Assessment Scale. Associations between each of the 4 APS subscales in the CAARMS—non‐bizarre ideas (NBI), perceptual abnormalities (PA), unusual thought content (UTC) and disorganized speech (DS)—with its distress level were examined.Results: Of the 173 UHR participants, 154 (89%) reported distress related to one or more APS. NBI was rated to be the most distressing out of the 4 APS by the highest number of participants (32.9%) compared to UTC (12.1%), PA (24.9%) and DS (2.9%). Mean distress scores were significantly associated with CAARMS composite scores (P < .001). However, there was no significant relationship between distress scores and functioning. Both mean distress scores (OR = 1.034, P = .029) and functioning (OR = 0.892, P = .022) were significant predictors of transition to psychosis at 1 year of follow‐up.Conclusions: This study provides additional evidence to link subjective distress experienced by UHR individuals to APS and to their subsequent clinical outcomes and has significant clinical implications.